Zota Healthcare Intrinsic Value
ZOTA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹286.88 | ₹258.19 - ₹315.57 | -80.0% | Book Value/Share: ₹78.28, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹430.32 | ₹387.29 - ₹473.35 | -70.0% | Revenue/Share: ₹180.69, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹573.76 | ₹516.38 - ₹631.14 | -60.0% | EBITDA: ₹32.00Cr, EV/EBITDA: 10x |
Want to compare with current market value? Check ZOTA share price latest .
Valuation Comparison Chart
ZOTA Intrinsic Value Analysis
What is the intrinsic value of ZOTA?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Zota Healthcare (ZOTA) is ₹430.32 (median value). With the current market price of ₹1434.40, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹286.88 to ₹573.76, indicating ₹286.88 - ₹573.76.
Is ZOTA undervalued or overvalued?
Based on our multi-method analysis, Zota Healthcare (ZOTA) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.66 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.93 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -28.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.19x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Zota Healthcare
Additional stock information and data for ZOTA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-50 Cr | ₹-96 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹13 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |